- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06201052
Impact of Exercise on Immune System and Metabolism in Football Players (IEISM)
The Influence of Physical Exercise on Chosen Parameters of the Immune System, Prooxidant-Antioxidant Balance, and Iron Metabolism in Football Players With Various Training Levels
Physical exercise, especially of high intensity, is a significant burden to the athlete's body. It should be emphasized that achieving high results in competitive sports requires significant, sometimes extreme, exercise loads during training, which may result in homeostasis disorders, adversely affecting athletes' fitness. Intense and prolonged physical exercise elevates reactive oxygen species, potentially impacting immune function. The mechanism, particularly in high-intensity activities, remains incompletely understood. Excessive oxygen radicals may induce metabolic changes, causing rapid erythrocyte damage and elevated redox-active free iron. This iron increase can be harmful, increasing oxidative stress and immune system activation. The sustained negative impact that may be observed even during post-workout recovery needs further exploration.
"This study aims to explain the impact of an intense exercise test on the immune system, pro-antioxidant balance, and iron metabolism in athletes with varying training levels. The primary questions it seeks to address are:
- How do athletes' experience and training background influence the immune system's response, pro-antioxidant balance, and iron regulation?
- Can the level of adaptation to physical exercise (training status) affect the rate of regeneration and the time required to return to pre-exercise homeostasis?"
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Poznań, Poland, 61-871
- Poznań University of Physical Education
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Competitive football training for at least 3 years
- Male
- Not taking any medications throughout the study
- Provide voluntary consent for participation in the study
Exclusion Criteria:
- Any healthy problems
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Junior
Junior soccer players 19 male, average training experience: 8 years
|
Beep Test for measuring aerobic power
|
|
Senior
Senior Soccer players 21 male, average training experience: 16 years
|
Beep Test for measuring aerobic power
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in iron level
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of iron management
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in hepcidin
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of iron management
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in lactoferrin
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of iron management
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in tryptophan
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of immune response
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in testosterone
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of hormonal response
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in cortisol
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of hormonal response
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in serotonin
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of neurohormonal response
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in myoglobin
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of muscle damage
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in UIBC (unsaturated iron-binding capacity)
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of iron management
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in TIBC (total iron-binding capacity)
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of iron management
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in IL-6 (interleukin-6)
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of immune system
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in IL-10 (interleukin-10)
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of immune system
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in TNF-α (tumor necrosis factor-alpha)
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of immune response
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
|
Changes in IGF-1 (insulin-like growth factor 1)
Time Frame: At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
marker of hormonal response
|
At rest (before the exercise test), 1 minute after the end of the test, after 3 hours, and 24 hours of recovery.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Joanna Ostapiuk-Karolczuk, Ph.D., Poznań University of Physical Education
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 382/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.